Autoimmune Disease Diagnosis Market Size, Trends, Analysis, and Outlook By Disease (Systemic Autoimmune Disease, Localized Autoimmune Disease), By Diagnosis (Antinuclear Antibody Tests, Autoantibody Tests, Complete Blood Count (CBC), C-reactive Protein (CRP), Urinalysis, Others), by Country, Segment, and Companies, 2024-2032
The global Autoimmune Disease Diagnosis market size is poised to register 7.1% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Autoimmune Disease Diagnosis market across By Disease (Systemic Autoimmune Disease, Localized Autoimmune Disease), By Diagnosis (Antinuclear Antibody Tests, Autoantibody Tests, Complete Blood Count (CBC), C-reactive Protein (CRP), Urinalysis, Others)
The autoimmune disease diagnosis market is driven by the increasing prevalence of autoimmune disorders, advancements in diagnostic technologies, and the need for accurate and timely disease detection. By 2030, the market is expected to witness robust growth, driven by innovations in autoimmune biomarkers, multiplex immunoassays, and point-of-care testing devices. Further, expanding applications in rheumatology, dermatology, and neurology are anticipated to drive market expansion, enabling early diagnosis, disease monitoring, and personalized treatment strategies for patients with autoimmune diseases.
Autoimmune Disease Diagnosis Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Autoimmune Disease Diagnosis market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Autoimmune Disease Diagnosis survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Autoimmune Disease Diagnosis industry.
Key market trends defining the global Autoimmune Disease Diagnosis demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Autoimmune Disease Diagnosis Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Autoimmune Disease Diagnosis industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Autoimmune Disease Diagnosis companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Autoimmune Disease Diagnosis industry
Leading Autoimmune Disease Diagnosis companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Autoimmune Disease Diagnosis companies.
Autoimmune Disease Diagnosis Market Study- Strategic Analysis Review
The Autoimmune Disease Diagnosis market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Autoimmune Disease Diagnosis industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Autoimmune Disease Diagnosis Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Autoimmune Disease Diagnosis Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Autoimmune Disease Diagnosis market segments. Similarly, Strong market demand is encouraging Canadian Autoimmune Disease Diagnosis companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Autoimmune Disease Diagnosis market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Autoimmune Disease Diagnosis Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Autoimmune Disease Diagnosis industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Autoimmune Disease Diagnosis market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Autoimmune Disease Diagnosis Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Autoimmune Disease Diagnosis in Asia Pacific. In particular, China, India, and South East Asian Autoimmune Disease Diagnosis markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Autoimmune Disease Diagnosis Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Autoimmune Disease Diagnosis Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Autoimmune Disease Diagnosis market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Autoimmune Disease Diagnosis.
Autoimmune Disease Diagnosis Market Company Profiles
The global Autoimmune Disease Diagnosis market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbott Laboratories, bioMйrieux SA, Bio-Rad Laboratories Inc, DIAsource ImmunoAssays SA, EUROIMMUN Medizinische Labordiagnostika AG, Exagen Inc, F. Hoffmann-La Roche Ltd, Grifols S.A., Inova Diagnostics Inc, Myriad Genetics Inc, R-Biopharm AG, Siemens Healthineers AG, Thermo Fisher Scientific Inc, Trinity Biotech plc.
Recent Autoimmune Disease Diagnosis Market Developments
The global Autoimmune Disease Diagnosis market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Autoimmune Disease Diagnosis Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Disease
Systemic Autoimmune Disease
-Rheumatoid Arthritis
-Psoriasis
-Systemic Lupus Erythematosus (SLE)
-Multiple Sclerosis
-Others
Localized Autoimmune Disease
-Inflammatory Bowel Disease
-Type 1 Diabetes
-Thyroid
-Others
By Diagnosis
Antinuclear Antibody Tests
Autoantibody Tests
Complete Blood Count (CBC)
C-reactive Protein (CRP)
Urinalysis
Others
Geographical Segmentation:
Abbott Laboratories
bioMйrieux SA
Bio-Rad Laboratories Inc
DIAsource ImmunoAssays SA
EUROIMMUN Medizinische Labordiagnostika AG
Exagen Inc
F. Hoffmann-La Roche Ltd
Grifols S.A.
Inova Diagnostics Inc
Myriad Genetics Inc
R-Biopharm AG
Siemens Healthineers AG
Thermo Fisher Scientific Inc
Trinity Biotech plc
Formats Available: Excel, PDF, and PPT
The autoimmune disease diagnosis market is driven by the increasing prevalence of autoimmune disorders, advancements in diagnostic technologies, and the need for accurate and timely disease detection. By 2030, the market is expected to witness robust growth, driven by innovations in autoimmune biomarkers, multiplex immunoassays, and point-of-care testing devices. Further, expanding applications in rheumatology, dermatology, and neurology are anticipated to drive market expansion, enabling early diagnosis, disease monitoring, and personalized treatment strategies for patients with autoimmune diseases.
Autoimmune Disease Diagnosis Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Autoimmune Disease Diagnosis market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Autoimmune Disease Diagnosis survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Autoimmune Disease Diagnosis industry.
Key market trends defining the global Autoimmune Disease Diagnosis demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Autoimmune Disease Diagnosis Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Autoimmune Disease Diagnosis industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Autoimmune Disease Diagnosis companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Autoimmune Disease Diagnosis industry
Leading Autoimmune Disease Diagnosis companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Autoimmune Disease Diagnosis companies.
Autoimmune Disease Diagnosis Market Study- Strategic Analysis Review
The Autoimmune Disease Diagnosis market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Autoimmune Disease Diagnosis industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Autoimmune Disease Diagnosis Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Autoimmune Disease Diagnosis Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Autoimmune Disease Diagnosis market segments. Similarly, Strong market demand is encouraging Canadian Autoimmune Disease Diagnosis companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Autoimmune Disease Diagnosis market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Autoimmune Disease Diagnosis Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Autoimmune Disease Diagnosis industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Autoimmune Disease Diagnosis market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Autoimmune Disease Diagnosis Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Autoimmune Disease Diagnosis in Asia Pacific. In particular, China, India, and South East Asian Autoimmune Disease Diagnosis markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Autoimmune Disease Diagnosis Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Autoimmune Disease Diagnosis Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Autoimmune Disease Diagnosis market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Autoimmune Disease Diagnosis.
Autoimmune Disease Diagnosis Market Company Profiles
The global Autoimmune Disease Diagnosis market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbott Laboratories, bioMйrieux SA, Bio-Rad Laboratories Inc, DIAsource ImmunoAssays SA, EUROIMMUN Medizinische Labordiagnostika AG, Exagen Inc, F. Hoffmann-La Roche Ltd, Grifols S.A., Inova Diagnostics Inc, Myriad Genetics Inc, R-Biopharm AG, Siemens Healthineers AG, Thermo Fisher Scientific Inc, Trinity Biotech plc.
Recent Autoimmune Disease Diagnosis Market Developments
The global Autoimmune Disease Diagnosis market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Autoimmune Disease Diagnosis Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Disease
Systemic Autoimmune Disease
-Rheumatoid Arthritis
-Psoriasis
-Systemic Lupus Erythematosus (SLE)
-Multiple Sclerosis
-Others
Localized Autoimmune Disease
-Inflammatory Bowel Disease
-Type 1 Diabetes
-Thyroid
-Others
By Diagnosis
Antinuclear Antibody Tests
Autoantibody Tests
Complete Blood Count (CBC)
C-reactive Protein (CRP)
Urinalysis
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Abbott Laboratories
bioMйrieux SA
Bio-Rad Laboratories Inc
DIAsource ImmunoAssays SA
EUROIMMUN Medizinische Labordiagnostika AG
Exagen Inc
F. Hoffmann-La Roche Ltd
Grifols S.A.
Inova Diagnostics Inc
Myriad Genetics Inc
R-Biopharm AG
Siemens Healthineers AG
Thermo Fisher Scientific Inc
Trinity Biotech plc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Autoimmune Disease Diagnosis Market Overview and Key Findings, 2024
1.2 Autoimmune Disease Diagnosis Market Size and Growth Outlook, 2021- 2030
1.3 Autoimmune Disease Diagnosis Market Growth Opportunities to 2030
1.4 Key Autoimmune Disease Diagnosis Market Trends and Challenges
1.4.1 Autoimmune Disease Diagnosis Market Drivers and Trends
1.4.2 Autoimmune Disease Diagnosis Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Autoimmune Disease Diagnosis Companies
2. AUTOIMMUNE DISEASE DIAGNOSIS MARKET SIZE OUTLOOK TO 2030
2.1 Autoimmune Disease Diagnosis Market Size Outlook, USD Million, 2021- 2030
2.2 Autoimmune Disease Diagnosis Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. AUTOIMMUNE DISEASE DIAGNOSIS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. AUTOIMMUNE DISEASE DIAGNOSIS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Disease
Systemic Autoimmune Disease
-Rheumatoid Arthritis
-Psoriasis
-Systemic Lupus Erythematosus (SLE)
-Multiple Sclerosis
-Others
Localized Autoimmune Disease
-Inflammatory Bowel Disease
-Type 1 Diabetes
-Thyroid
-Others
By Diagnosis
Antinuclear Antibody Tests
Autoantibody Tests
Complete Blood Count (CBC)
C-reactive Protein (CRP)
Urinalysis
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Autoimmune Disease Diagnosis Market, 2025
5.2 Asia Pacific Autoimmune Disease Diagnosis Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Autoimmune Disease Diagnosis Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Autoimmune Disease Diagnosis Market, 2025
5.5 Europe Autoimmune Disease Diagnosis Market Size Outlook by Type, 2021- 2030
5.6 Europe Autoimmune Disease Diagnosis Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Autoimmune Disease Diagnosis Market, 2025
5.8 North America Autoimmune Disease Diagnosis Market Size Outlook by Type, 2021- 2030
5.9 North America Autoimmune Disease Diagnosis Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Autoimmune Disease Diagnosis Market, 2025
5.11 South America Pacific Autoimmune Disease Diagnosis Market Size Outlook by Type, 2021- 2030
5.12 South America Autoimmune Disease Diagnosis Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Autoimmune Disease Diagnosis Market, 2025
5.14 Middle East Africa Autoimmune Disease Diagnosis Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Autoimmune Disease Diagnosis Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Autoimmune Disease Diagnosis Market Size Outlook and Revenue Growth Forecasts
6.2 US Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Autoimmune Disease Diagnosis Industry Drivers and Opportunities
7. AUTOIMMUNE DISEASE DIAGNOSIS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. AUTOIMMUNE DISEASE DIAGNOSIS COMPANY PROFILES
8.1 Profiles of Leading Autoimmune Disease Diagnosis Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abbott Laboratories
bioMйrieux SA
Bio-Rad Laboratories Inc
DIAsource ImmunoAssays SA
EUROIMMUN Medizinische Labordiagnostika AG
Exagen Inc
F. Hoffmann-La Roche Ltd
Grifols S.A.
Inova Diagnostics Inc
Myriad Genetics Inc
R-Biopharm AG
Siemens Healthineers AG
Thermo Fisher Scientific Inc
Trinity Biotech plc.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Autoimmune Disease Diagnosis Market Overview and Key Findings, 2024
1.2 Autoimmune Disease Diagnosis Market Size and Growth Outlook, 2021- 2030
1.3 Autoimmune Disease Diagnosis Market Growth Opportunities to 2030
1.4 Key Autoimmune Disease Diagnosis Market Trends and Challenges
1.4.1 Autoimmune Disease Diagnosis Market Drivers and Trends
1.4.2 Autoimmune Disease Diagnosis Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Autoimmune Disease Diagnosis Companies
2. AUTOIMMUNE DISEASE DIAGNOSIS MARKET SIZE OUTLOOK TO 2030
2.1 Autoimmune Disease Diagnosis Market Size Outlook, USD Million, 2021- 2030
2.2 Autoimmune Disease Diagnosis Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. AUTOIMMUNE DISEASE DIAGNOSIS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. AUTOIMMUNE DISEASE DIAGNOSIS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Disease
Systemic Autoimmune Disease
-Rheumatoid Arthritis
-Psoriasis
-Systemic Lupus Erythematosus (SLE)
-Multiple Sclerosis
-Others
Localized Autoimmune Disease
-Inflammatory Bowel Disease
-Type 1 Diabetes
-Thyroid
-Others
By Diagnosis
Antinuclear Antibody Tests
Autoantibody Tests
Complete Blood Count (CBC)
C-reactive Protein (CRP)
Urinalysis
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Autoimmune Disease Diagnosis Market, 2025
5.2 Asia Pacific Autoimmune Disease Diagnosis Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Autoimmune Disease Diagnosis Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Autoimmune Disease Diagnosis Market, 2025
5.5 Europe Autoimmune Disease Diagnosis Market Size Outlook by Type, 2021- 2030
5.6 Europe Autoimmune Disease Diagnosis Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Autoimmune Disease Diagnosis Market, 2025
5.8 North America Autoimmune Disease Diagnosis Market Size Outlook by Type, 2021- 2030
5.9 North America Autoimmune Disease Diagnosis Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Autoimmune Disease Diagnosis Market, 2025
5.11 South America Pacific Autoimmune Disease Diagnosis Market Size Outlook by Type, 2021- 2030
5.12 South America Autoimmune Disease Diagnosis Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Autoimmune Disease Diagnosis Market, 2025
5.14 Middle East Africa Autoimmune Disease Diagnosis Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Autoimmune Disease Diagnosis Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Autoimmune Disease Diagnosis Market Size Outlook and Revenue Growth Forecasts
6.2 US Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Autoimmune Disease Diagnosis Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Autoimmune Disease Diagnosis Industry Drivers and Opportunities
7. AUTOIMMUNE DISEASE DIAGNOSIS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. AUTOIMMUNE DISEASE DIAGNOSIS COMPANY PROFILES
8.1 Profiles of Leading Autoimmune Disease Diagnosis Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abbott Laboratories
bioMйrieux SA
Bio-Rad Laboratories Inc
DIAsource ImmunoAssays SA
EUROIMMUN Medizinische Labordiagnostika AG
Exagen Inc
F. Hoffmann-La Roche Ltd
Grifols S.A.
Inova Diagnostics Inc
Myriad Genetics Inc
R-Biopharm AG
Siemens Healthineers AG
Thermo Fisher Scientific Inc
Trinity Biotech plc.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
